Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Share price at the NSE close on 29 Oct 2026. Previous close ₹648.50.
29 Oct: open ₹667.95, high ₹680.90, low ₹652.75
- Under NSE's long-term additional surveillance, stage IV, on the list for 29 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,240 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 44.92
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.61
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.22%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,47,694
Bliss GVS Pharma results
64 filed, newest first. Page 1 of 2.
Oct 2026
29 Oct · Results
Aug 2026
May 2026
12 May · Results
Nov 2025
6 Nov · Results
Jul 2025
29 Jul · Results
May 2025
12 May · Results
12 May · Results
Jan 2025
28 Jan · Results
Oct 2024
24 Oct · Results
Jul 2024
24 Jul · Results
May 2024
2 May · Results
Jan 2024
23 Jan · Results
Nov 2023
1 Nov · Results
Aug 2023
1 Aug · Results
May 2023
11 May · Results
Jan 2023
24 Jan · Results
Apr 2022
30 Apr · Results
Jan 2022
29 Jan · Results
Oct 2021
30 Oct · Results
Jul 2021
31 Jul · Results
May 2021
11 May · Results
Jan 2021
21 Jan · Results
Oct 2020
21 Oct · Results
Aug 2020
20 Aug · Results
Jun 2020
16 Jun · Results
Feb 2020
12 Feb · Results
Nov 2019
11 Nov · Results
Aug 2019
12 Aug · Results
May 2019
20 May · Results
Jan 2019
29 Jan · Results
Nov 2018
2 Nov · Results
Aug 2018
9 Aug · Results
May 2018
18 May · Results
Jan 2018
19 Jan · Results
Nov 2017
30 Nov · Results
Sep 2017
6 Sep · Results
May 2017
16 May · Results
Feb 2017
9 Feb · Results
Oct 2016
26 Oct · Results
Jul 2016
May 2016
Feb 2016
Nov 2015
Aug 2015
May 2015
Feb 2015
Oct 2014
Aug 2014